This story originally ran on June 22 and has been updated to clarify comments made by Hedrick regarding the FDA's IVDMIA guidelines.

By Adam Bonislawski

Molecular diagnostics firm Biodesix announced this week that it has received a US patent for its VeriStat protein biomarker-based lung cancer serum test.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.